Diageo plc (DEO) Stock Price & How to Invest

Diageo plc is the largest spirits producer in the world by value, selling in roughly 180 markets from a portfolio that spans Johnnie Walker, Buchanan's and other Scotch, Smirnoff and Ketel One vodka, Tanqueray and Gordon's gin, Captain Morgan rum, Crown Royal Canadian whisky, Bulleit bourbon, Baileys, the Don Julio and Casamigos tequilas, and Guinness stout. It also holds controlling stakes in listed subsidiaries including United Spirits in India, and has been reshaping the edges of the group: East Africa Breweries is being sold with completion expected in calendar H2 2026, and United Spirits is divesting the Royal Challengers Bengaluru cricket franchise. The economics are those of a branded-goods owner rather than a manufacturer, with pricing power, long aging cycles for whisky and tequila that tie up working capital, and distribution scale that is hard to replicate.

The investment picture in August 2026 is a turnaround under new management. Fiscal 2026 (year ended 30 June 2026) net sales were ~$19.6 billion, down ~3.0% reported and ~2.0% organically, with volume down ~0.4% and price/mix down ~1.6% as North America and Asia Pacific offset growth in Europe, Latin America and Africa. Sir Dave Lewis, who ran the Tesco turnaround, became chief executive at the start of 2026 after Debra Crew's departure in July 2025, and has set out roughly $1 billion of savings over three years, a rebased dividend policy and a deleveraging path from ~3.1x net debt to adjusted EBITDA. Reported operating profit fell ~27% to ~$3.2 billion on ~$1.5 billion of impairments and ~$0.9 billion of restructuring charges, while operating profit before exceptional items rose ~2% organically to ~$5.7 billion at a ~28.9% margin. The debate is whether cost cuts and mix repair can carry earnings while US spirits consumption stays soft.

The core risk is that the spirits downturn is structural rather than cyclical: US consumption has been falling since the post-pandemic peak, and moderation trends among younger drinkers, GLP-1 weight-loss drugs and cannabis substitution are all cited as reasons the volume base may not recover to prior trend. Leverage at ~3.1x limits flexibility, and the ~$1.5 billion of fiscal 2026 impairments (largely Turkiye hyperinflation accounting plus the Don Papa writedown) shows how quickly acquired brand value can be marked down. Tariffs of roughly $200 million a year are a live cost that depends on trade policy Diageo does not control, and the aged inventory model means production decisions made years ago cannot be reversed if demand shifts. Currency translation matters too, since Diageo reports in US dollars but earns across dozens of currencies, and the ADR adds depositary fees on top. There is also open consumer litigation over the labelling of Casamigos and Don Julio as 100% blue weber agave, pending in the Eastern District of New York, and a new chief executive's cost program of this size carries its own execution risk on brand investment and talent.

7 analysts publish price targets on DEO, averaging $106.43 against a $93.96 price as of August 2026, or +13.3%. The published targets run from $76.00 to $136.00, a moderate spread, and the ratings split 4 buy, 3 hold, 1 sell. Over the last six months there has been 1 raise and 0 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full DEO forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Diageo plc. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. The cost program and margin defence. The prior Accelerate program delivered ~$540 million of savings in fiscal 2026, and the new operating framework targets ~$850 million over two years starting in fiscal 2027, with another ~$150 million from supply chain work, for roughly $1 billion in total. The most optimistic published target, $136.00, assumes this works close to its best case.

The case against. The core risk is that the spirits downturn is structural rather than cyclical: US consumption has been falling since the post-pandemic peak, and moderation trends among younger drinkers, GLP-1 weight-loss drugs and cannabis substitution are all cited as reasons the volume base may not recover to prior trend. The most pessimistic target, $76.00, is roughly what DEO is worth if this bites instead.

Read the full bull and bear case on DEO, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Diageo plc's investor relations page or your broker.

• Net sales (FY2026): ~$19.6B, -3.0% reported, -2.0% organic
• Operating profit (before exceptionals): ~$5.7B, ~28.9% margin
• EPS before exceptional items: ~165.3c per share (~$6.61 per ADR)
• Free cash flow (FY2026): ~$3.2B
• Net debt / adjusted EBITDA: ~$20.5B, ~3.1x
• Market cap: ~$52B at ~$94 per ADR

At roughly $94 per ADR against ~$6.61 of ADR-equivalent earnings before exceptional items, DEO trades near ~14x, well below the 20x-plus multiple it carried through the 2010s and much of the pandemic era. The reported figure looks very different: basic EPS of ~78.1 cents (~$3.12 per ADR) reflects ~$1.5 billion of impairments and ~$0.9 billion of restructuring, so the headline P/E on statutory earnings is roughly double. Enterprise value including ~$20.5 billion of net debt is around $73 billion, or roughly 11x adjusted EBITDA.

Other names that sit close to DEO: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get DEO exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so DEO sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where DEO fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

Diageo still owns one of the strongest brand portfolios in alcohol, but the ADR now prices a business fixing margins and leverage while its top line shrinks, so the case rests on whether cost savings arrive faster than spirits demand erodes.

Whether DEO is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is DEO a buy or a sell?, and where the stock could go from here in the DEO stock forecast.

For income investors, whether DEO pays a dividend and how the payout looks is covered in does DEO pay a dividend? And to weigh DEO against a peer, read the full side-by-side comparisons: DEO vs AB and DEO vs STZ.